Click to rate this post!
[Total: 0 Your Rating: 0]You must sign in to vote
Elly receives investment from multinational pharmaceutical company Bayer & campaign closing soon
Elly, an empathetic audio companion for cancer patients, recently received a €100K investment from Bayer AG. Bayer’s investment will be used by Elly to develop an initial working prototype of a cardiometabolic audio companion offering. Bayer, one of the world’s largest pharmaceutical companies, has achieved over €43B in total sales and has been listed on the Fortune 500 list for over two decades.
Additional deal highlights & campaign updates to date include:
• Partnerships with Top Hospitals | Company partnered with Cedars-Sinai Health System, one of the largest nonprofit academic medical centers in the U.S., to research the effect of companionship on cancer patient mental health. Additionally, Elly’s app will be deployed across all inpatient beds (2K+) at Houston Methodist, the number 1 hospital in Texas.
• Notable Investors | In addition to Bayer’s recent investment, Elly is backed by Google, JumpStart Foundry, StartUp Health, and Nex Cubed.
• Product | In a company conducted clinical study of 100 patients, users reported a 15% improvement in Quality of Life score. The app achieved an 88% user retention rate after one month, which is nearly 6x higher than average health app retention rate (15%).
• Team | Company is led by experienced founders who have previously co-founded companies such as CancerAid, HotDoc, Vivi, and Papercloud. Hotdoc is one of Australia’s leading patient engagement platform with over 5M patients and CancerAid was identified as a top cancer app in the world that helps cancer patients track their symptoms. During co-founder Dr. Nikhil Pooviah’s tenure, CancerAid pitched and secured a $500K deal on Shark Tank.